Astrix Innovators Forum

Digital Transformation of Cell Culture, Cell Manufacturing, and Cell Banking

• Date:  March 24, 2022 1:00 EST
• Company:  CellPort Software
• Presenter:  Patrick Dentinger , CEO, CellPort Software

Overview:

Gene therapy, cell therapy, in vitro pharmaceutical testing, and cultured meat markets all rely upon the culturing, manufacturing, and banking of cells. That said, one of the major factors restraining the growth of these markets is the lack of proper infrastructure for cell-based research activities. Legacy ELN and LIMS systems are ill-equipped to handle the complexities of the cell manufacturing data and workflows, resulting in a patchwork of unscalable systems including paper lab notebooks and Excel spreadsheets.

This webinar introduces the CellPort Cell Culture Suite, a secure, compliant SaaS-based application suite focused on managing all lab workflows, activities, equipment, materials, personnel, data/calculations, locations, and projects for cell culture, cell manufacturing, and cell banking. The CellPort Cell Culture Suite increases operational efficiency, reduces errors, increases reproducibility, enhances productivity, and provides full audit-ready traceability from research through GLP and GMP.

Who should attend?

• Scientists, Laboratory Managers/Directors/VPs, and QA/QC Managers/Directors/VPs involved with cell manufacturing and cell banking.

What you will learn:

• How cell manufacturing is critical to the future of drug discovery and advanced therapy medicinal products including cell and gene therapy.
• How the lack of proper infrastructure for cell culture, cell manufacturing, and cell banking adversely impacts operational efficiency.
• How digitalization transformation of cell culture and cell banking in R&D, GLP, and GMP settings dramatically increases operational efficiency by allowing every aspect of a cell’s life to be captured digitally, permitting seamless searching, sharing, tracing, transferring, and auditing.